Argus Research Maintains Buy on Medtronic, Raises Price Target to $165
Argus Research analyst David Toung maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $150 to $165.
The Daily Biotech Pulse: Early Approval For Ascendis’ Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 25)
Expert Ratings For Medtronic
Analysts have provided the following ratings for Medtronic (NYSE:MDT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Truist Securities Maintains Buy on Medtronic, Raises Price Target to $148
Truist Securities analyst Kaila Krum maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $138 to $148.
Citigroup Maintains Buy on Medtronic, Raises Price Target to $153, Added to Focus List
Citigroup analyst Joanne Wuensch maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $143 to $153, Added to Focus List.
UBS Maintains Buy on Medtronic, Raises Price Target to $149
UBS analyst Matthew Taylor maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $145 to $149.
Stifel Maintains Buy on Medtronic, Raises Price Target to $145
Stifel analyst Rick Wise maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $140 to $145.
Morgan Stanley Maintains Overweight on Medtronic, Raises Price Target to $154
Morgan Stanley analyst David Lewis maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $140 to $154.
10 Biggest Price Target Changes For Wednesday
Wells Fargo raised the price target for Urban Outfitters, Inc. (NASDAQ: URBN) from $35 to $40. Urban Outfitters fell 5.1% to $38.65 in pre-market trading.
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer’s Drug
ere's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 24)